March 24 (Reuters) - Oncorus Inc ONCR.O :
* ONCORUS REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* ONCORUS INC: ON TRACK TO SUBMIT IND FOR ONCR-021 IN
MID-2023
* ONCORUS INC: ENDED QUARTER WITH $62.2 MILLION IN CASH,
CASH
EQUIVALENTS AND INVESTMENTS TO SUPPORT NEXT-GENERATION RNA
THERAPEUTICS PIPELINE
* ONCORUS INC: EXPECTS ITS CASH, CASH EQUIVALENTS AND
INVESTMENTS
TO FUND ITS CAPITAL EXPENDITURES AND OPERATING EXPENSES INTO
EARLY 2024
* ONCORUS INC - QTRLY LOSS PER SHARE $0.81
Source text for Eikon: ID:nGNX2H56yZ
Further company coverage: ONCR.O
((Reuters.Briefs@thomsonreuters.com;))